Geriatric Research, Education and Clinical Center (GRECC), Miami VA Healthcare System, Miami, Florida, USA.
Department of Medicine, University of Miami, Jackson Health System, Miami, Florida, USA.
J Am Geriatr Soc. 2022 Nov;70(11):3163-3175. doi: 10.1111/jgs.17977. Epub 2022 Aug 6.
Frailty, a state of vulnerability to stressors resulting from loss of physiological reserve due to multisystemic dysfunction, is common among hospitalized older adults. Hospital clinicians need objective and practical instruments that identify older adults with frailty. The FI-LAB is based on laboratory values and vital signs and may capture biological changes of frailty that predispose hospitalized older adults to complications. The study's aim was to assess the association of the FI-LAB versus VA-FI with hospital and post-hospital clinical outcomes in older adults.
Retrospective cohort study was conducted on Veterans aged ≥60 admitted to a VA hospital. We identified acute hospitalizations January 2011-December-2014 with 1-year follow-up. A 31-item FI-LAB was created from blood laboratory tests and vital signs collected within the first 48 h of admission and scores were categorized as low (<0.25), moderate (0.25-0.40), and high (>0.40). For each FI-LAB group, we obtained odds ratio (OR) and confidence intervals (CI) for hospital and post-hospital outcomes using multivariate binomial logistic regression. Additionally, we calculated hazard ratios (HR) and CI for all-cause in-hospital mortality comparing the high and moderate FI-LAB group with the low group.
Patients were 1407 Veterans, mean age 72.7 (SD = 9.0), 67.8% Caucasian, 96.1% males, 47.0% (n = 661), 41.0% (n = 577), and 12.0% (n = 169) were in the low, moderate, and high FI-LAB groups, respectively. Moderate and high scores were associated with prolonged LOS, OR:1.62 (95% CI:1.29-2.03); and 3.36 (95% CI:2.27-4.99), ICU admission, OR:1.40 (95% CI:1.03-1.90); and OR:2.00 (95% CI:1.33-3.02), nursing home placement OR:2.36 (95% CI:1.26-4.44); and 5.99 (95% CI:2.83-12.70), 30-day readmissions OR:1.74 (95% CI:1.20-2.52); and 2.20 (95% CI:1.30-3.74), 30-day mortality OR: 2.51 (95% CI:1.01-6.23); and 8.97 (95% CI:3.42-23.53), 6-month mortality OR:3.00 (95% CI:1.90-4.74); and 6.16 (95% CI:3.55-10.71), and 1-year mortality OR: 2.66 (95% CI:1.87-3.79); and 4.76 (95% CI:3.00-7.54) respectively. The high FI-LAB group showed higher risk of in-hospital mortality, HR:18.17 (95% CI:4.01-80.52) with an area-under-the-curve of 0.843 (95% CI:0.75-0.93).
High and moderate FI-LAB scores were associated with worse in-hospital and post-hospital outcomes. The FI-LAB may identify hospitalized older patients with frailty at higher risk and assist clinicians in implementing strategies to improve outcomes.
衰弱是一种由于多系统功能障碍导致生理储备减少而对压力源敏感的状态,在住院老年患者中较为常见。医院临床医生需要能够识别衰弱的老年患者的客观实用工具。FI-LAB 基于实验室值和生命体征,可以捕捉导致住院老年患者发生并发症的衰弱的生物学变化。本研究的目的是评估 FI-LAB 与 VA-FI 与老年患者的医院和出院后临床结局的相关性。
对≥60 岁的退伍军人进行回顾性队列研究,这些退伍军人入住退伍军人事务部医院,随访 1 年。在入院后 48 小时内创建了 31 项 FI-LAB,由血液实验室检查和生命体征组成,评分分为低(<0.25)、中(0.25-0.40)和高(>0.40)。对于每个 FI-LAB 组,我们使用多元二项逻辑回归获得了医院和出院后结果的比值比(OR)和置信区间(CI)。此外,我们计算了所有原因住院死亡率的风险比(HR)和 CI,将高和中 FI-LAB 组与低组进行比较。
患者为 1407 名退伍军人,平均年龄为 72.7(标准差=9.0),67.8%为白种人,96.1%为男性,47.0%(n=661)、41.0%(n=577)和 12.0%(n=169)分别为低、中、高 FI-LAB 组。中、高评分与 LOS 延长有关,OR:1.62(95%CI:1.29-2.03);和 3.36(95%CI:2.27-4.99),ICU 入院,OR:1.40(95%CI:1.03-1.90);和 OR:2.00(95%CI:1.33-3.02),护理院安置,OR:2.36(95%CI:1.26-4.44);和 5.99(95%CI:2.83-12.70),30 天再入院,OR:1.74(95%CI:1.20-2.52);和 2.20(95%CI:1.30-3.74),30 天死亡率,OR:2.51(95%CI:1.01-6.23);和 8.97(95%CI:3.42-23.53),6 个月死亡率,OR:3.00(95%CI:1.90-4.74);和 6.16(95%CI:3.55-10.71),1 年死亡率,OR:2.66(95%CI:1.87-3.79);和 4.76(95%CI:3.00-7.54)。高 FI-LAB 组的院内死亡率较高,HR:18.17(95%CI:4.01-80.52),曲线下面积为 0.843(95%CI:0.75-0.93)。
高和中 FI-LAB 评分与住院和出院后较差的临床结局相关。FI-LAB 可能会识别出衰弱风险较高的住院老年患者,并帮助临床医生实施改善结局的策略。